Malorni L, Tyekucheva S, Gombos A, Hasler-Strub U, et al. Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17) Ann Oncol 2025 Oct 16:S0923-7534(25)04963-4. doi: 10.1016/j.annonc.2025.
PMID: 41109527